These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17762317)

  • 1. An open-label trial of escitalopram in the treatment of pathological gambling.
    Black DW; Shaw M; Forbush KT; Allen J
    Clin Neuropharmacol; 2007; 30(4):206-12. PubMed ID: 17762317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
    Black DW; Arndt S; Coryell WH; Argo T; Forbush KT; Shaw MC; Perry P; Allen J
    J Clin Psychopharmacol; 2007 Apr; 27(2):143-50. PubMed ID: 17414236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended release carbamazepine in the treatment of pathological gambling: an open-label study.
    Black DW; Shaw MC; Allen J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1191-4. PubMed ID: 18436362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label trial of acamprosate in the treatment of pathological gambling.
    Black DW; McNeilly DP; Burke WJ; Shaw MC; Allen J
    Ann Clin Psychiatry; 2011 Nov; 23(4):250-6. PubMed ID: 22073381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.
    Möller HJ; Langer S; Schmauss M
    Pharmacopsychiatry; 2007 Mar; 40(2):53-7. PubMed ID: 17447173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study.
    Leinonen E; Niemi H
    Nord J Psychiatry; 2007; 61(2):109-14. PubMed ID: 17454725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I; Baruch Y; Barak Y
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial.
    Muller JE; Wentzel I; Koen L; Niehaus DJ; Seedat S; Stein DJ
    Int Clin Psychopharmacol; 2008 Jan; 23(1):43-8. PubMed ID: 18090507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological gambling: comorbid psychiatric diagnoses in patients and their families.
    Dannon PN; Lowengrub K; Aizer A; Kotler M
    Isr J Psychiatry Relat Sci; 2006; 43(2):88-92. PubMed ID: 16910370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
    Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
    J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P; Legault M
    Depress Anxiety; 2008; 25(12):E173-81. PubMed ID: 19006260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder.
    Pinto C; Trivedi JK; Vankar GK; Sharma PS; Narasimha V
    J Indian Med Assoc; 2007 Jul; 105(7):364, 366, 368 passim. PubMed ID: 18178988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.
    Schmitt L; Tonnoir B; Arbus C
    Neuropsychobiology; 2006; 54(4):201-7. PubMed ID: 17337913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surveillance study of escitalopram treatment of depressed patients.
    Anders M; Tuma I; Rösslerova H
    Expert Opin Pharmacother; 2008 Jan; 9(1):1-6. PubMed ID: 18076333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
    Grant JE; Potenza MN
    Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of treatment retention in pathological gambling.
    Grant JE; Kim SW; Kuskowski M
    Compr Psychiatry; 2004; 45(2):83-7. PubMed ID: 14999657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of escitalopram to paroxetine in the treatment of depression.
    Kasper S; Baldwin DS; Larsson Lönn S; Boulenger JP
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):229-37. PubMed ID: 19185467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram in seasonal affective disorder: results of an open trial.
    Pjrek E; Winkler D; Stastny J; Praschak-Rieder N; Willeit M; Kasper S
    Pharmacopsychiatry; 2007 Jan; 40(1):20-4. PubMed ID: 17327956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.